Cargando…

Correction: Integrated Proteomic Analysis of Human Cancer Cells and Plasma from Tumor Bearing Mice for Ovarian Cancer Biomarker Discovery

Detalles Bibliográficos
Autores principales:	Pitteri, Sharon J., JeBailey, Lellean, Faça, Vitor M., Thorpe, Jason D., Silva, Melissa A., Ireton, Reneé C., Horton, Marc B., Wang, Hong, Pruitt, Liese C., Zhang, Qing, Cheng, Kuang H., Urban, Nicole, Hanash, Samir M., Dinulescu, Daniela M.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795730/ http://dx.doi.org/10.1371/annotation/b29e7b74-4f55-4a44-8db6-e9480bef4872

Ejemplares similares

Integrated Proteomic Analysis of Human Cancer Cells and Plasma from Tumor Bearing Mice for Ovarian Cancer Biomarker Discovery
por: Pitteri, Sharon J., et al.
Publicado: (2009)

Proteomic Analysis of Ovarian Cancer Cells Reveals Dynamic Processes of Protein Secretion and Shedding of Extra-Cellular Domains
por: Faça, Vitor M., et al.
Publicado: (2008)

Knowledge-based analysis of proteomics data
por: Bessarabova, Marina, et al.
Publicado: (2012)

“Topological Significance” Analysis of Gene Expression and Proteomic Profiles from Prostate Cancer Cells Reveals Key Mechanisms of Androgen Response
por: Vellaichamy, Adaikkalam, et al.
Publicado: (2010)

A Systems Approach to the Proteomic Identification of Novel Cancer Biomarkers
por: Pitteri, Sharon, et al.
Publicado: (2010)

A mouse plasma peptide atlas as a resource for disease proteomics
por: Zhang, Qing, et al.
Publicado: (2008)

PreImplantation factor (PIF*) promotes embryotrophic and neuroprotective decidual genes: effect negated by epidermal growth factor
por: Duzyj, Christina M, et al.
Publicado: (2014)

Reconstitution of the ERG Gene Expression Network Reveals New Biomarkers and Therapeutic Targets in ERG Positive Prostate Tumors
por: Dubovenko, Alexey, et al.
Publicado: (2015)

A Mouse to Human Search for Plasma Proteome Changes Associated with Pancreatic Tumor Development
por: Faca, Vitor M, et al.
Publicado: (2008)

Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings
por: Katayama, Hiroyuki, et al.
Publicado: (2009)

Loss of E-cadherin disrupts ovarian epithelial inclusion cyst formation and collective cell movement in ovarian cancer cells
por: Choi, Pui-Wah, et al.
Publicado: (2015)

Lung cancer susceptibility beyond smoking history: opportunities and challenges
por: Hanash, Samir
Publicado: (2022)

Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor
por: Mizukami, Amanda, et al.
Publicado: (2019)

Plasma Proteome Profiles Associated with Inflammation, Angiogenesis, and Cancer
por: Kelly-Spratt, Karen S., et al.
Publicado: (2011)

RIG-I Like Receptors in Antiviral Immunity and Therapeutic Applications
por: Ireton, Reneé C., et al.
Publicado: (2011)

Impact of Protein Stability, Cellular Localization, and Abundance on Proteomic Detection of Tumor-Derived Proteins in Plasma
por: Fang, Qiaojun, et al.
Publicado: (2011)

A Proteomic Approach to the Identification of Lung Cancer Markers
por: Hanash, Samir, et al.
Publicado: (2001)

Proteomics Approaches to Identify Tumor Antigen Directed Autoantibodies as Cancer Biomarkers
por: Imafuku, Yuji, et al.
Publicado: (2004)

High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy
por: Davis, Michael A, et al.
Publicado: (2006)

Switching Roles of TGF-β in Cancer Development: Implications for Therapeutic Target and Biomarker Studies
por: Sun, Nan, et al.
Publicado: (2016)

Why have protein biomarkers not reached the clinic?
por: Hanash, Samir M
Publicado: (2011)

Disruption of the Clock Components CLOCK and BMAL1 Leads to Hypoinsulinemia and Diabetes
por: Marcheva, Biliana, et al.
Publicado: (2010)

Immunoadherence and complement in cancer-bearing mice.
por: Porta, C., et al.
Publicado: (1978)

Advances in Tumor Screening, Imaging, and Avatar Technologies for High-Grade Serous Ovarian Cancer
por: Ohman, Anders W., et al.
Publicado: (2014)

“Take it up a NOTCH: ” Novel strategies for cancer therapy
por: Morgan, Stefanie L., et al.
Publicado: (2013)

Extracellular Vesicles Mediate B Cell Immune Response and Are a Potential Target for Cancer Therapy
por: Kato, Taketo, et al.
Publicado: (2020)

Towards an integrated proteomic and glycomic approach to finding cancer biomarkers
por: Taylor, Allen D, et al.
Publicado: (2009)

A core function for p120-catenin in cadherin turnover
por: Davis, Michael A., et al.
Publicado: (2003)

iTRAQ-Based Proteomic Analysis of Polyploid Giant Cancer Cells and Budding Progeny Cells Reveals Several Distinct Pathways for Ovarian Cancer Development
por: Zhang, Shiwu, et al.
Publicado: (2013)

Extracellular Vesicles in Lung Cancer: Prospects for Diagnostic and Therapeutic Applications
por: Kato, Taketo, et al.
Publicado: (2021)

Intraperitoneal delivery of NanoOlaparib for disseminated late-stage cancer treatment
por: Baldwin, Paige, et al.
Publicado: (2018)

Tumor-Associated and Systemic Autoimmunity in Pre-Clinical Breast Cancer among Post-Menopausal Women
por: Parks, Christine G., et al.
Publicado: (2023)

Diverse Roles of SIRT1 in Cancer Biology and Lipid Metabolism
por: Simmons, Glenn E., et al.
Publicado: (2015)

Breast Cancer Knowledge Assessment of Health Workers in Ibadan, Southwest Nigeria
por: Pruitt, Liese C.C., et al.
Publicado: (2020)

Measuring human carboxylesterase 2 activity in pancreatic cancer patient-derived xenografts using a ratiometric fluorescent chemosensor
por: Kailass, Karishma, et al.
Publicado: (2019)

The AIRE G228W mutation disturbs the interaction of AIRE with its partner molecule SIRT1
por: Santos, Jadson C., et al.
Publicado: (2022)

Nanoformulation of Talazoparib Delays Tumor Progression and Ascites Formation in a Late Stage Cancer Model
por: Baldwin, Paige, et al.
Publicado: (2019)

Sustained delivery of PARP inhibitor Talazoparib for the treatment of BRCA-deficient ovarian cancer
por: Yang, Shicheng, et al.
Publicado: (2023)

Molecular mechanisms of cell–cell spread of intracellular bacterial pathogens
por: Ireton, Keith
Publicado: (2013)

Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice
por: Creighton, Chad, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_0qkroed9r90uq204u5mmvjb5vp